Abstract: The subject of the invention is pharmaceutical microspheres containing, as active principle, a mixture of valproic acid and of one of its pharmaceutically acceptable salts in combination with a matrix vehicle selected from glycerol esters, hydrogenated oils, esterified polyethylene glycols, waxes and their mixtures.
Type:
Application
Filed:
October 15, 2002
Publication date:
August 21, 2003
Applicant:
Sanofi-Synthelabo, a corporation of France.